Sartorius Aktiengesellschaft (SRT.DE)
EUR 177.8
(1.14%)
EUR 177.8
(1.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 205.2 Million EUR | -62.93% |
| 2022 | 913.1 Million EUR | 113.85% |
| 2021 | 426.97 Million EUR | 32.82% |
| 2020 | 321.47 Million EUR | 46.96% |
| 2019 | 218.74 Million EUR | 54.76% |
| 2018 | 141.34 Million EUR | 23.2% |
| 2017 | 114.73 Million EUR | 11.46% |
| 2016 | 102.93 Million EUR | -18.5% |
| 2015 | 126.3 Million EUR | 160.29% |
| 2014 | 48.52 Million EUR | -7.44% |
| 2013 | 52.42 Million EUR | 8.07% |
| 2012 | 48.51 Million EUR | -8.12% |
| 2011 | 52.79 Million EUR | 70.2% |
| 2010 | 31.02 Million EUR | 3081.54% |
| 2009 | 975 Thousand EUR | -94.01% |
| 2008 | 16.28 Million EUR | -45.96% |
| 2007 | 30.13 Million EUR | 3.84% |
| 2006 | 29.01 Million EUR | 31.75% |
| 2005 | 22.02 Million EUR | 44.59% |
| 2004 | 15.23 Million EUR | 238.74% |
| 2003 | 4.49 Million EUR | 1.08% |
| 2002 | 4.44 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 23.9 Million EUR | -34.88% |
| 2024 Q1 | 36.7 Million EUR | -46.73% |
| 2024 Q3 | 8.3 Million EUR | -65.27% |
| 2023 Q3 | 8.6 Million EUR | -93.41% |
| 2023 Q4 | 68.9 Million EUR | 701.16% |
| 2023 FY | 338.5 Million EUR | -62.93% |
| 2023 Q1 | 93.1 Million EUR | -54.59% |
| 2023 Q2 | 130.5 Million EUR | 40.17% |
| 2022 Q2 | 222.3 Million EUR | -19.81% |
| 2022 Q4 | 205 Million EUR | -1.68% |
| 2022 Q1 | 277.2 Million EUR | 1080.18% |
| 2022 FY | 913.1 Million EUR | 113.85% |
| 2022 Q3 | 208.5 Million EUR | -6.21% |
| 2021 Q3 | 105.6 Million EUR | -2.31% |
| 2021 Q4 | 23.48 Million EUR | -77.76% |
| 2021 FY | 426.97 Million EUR | 32.82% |
| 2021 Q1 | 82 Million EUR | 6.25% |
| 2021 Q2 | 108.1 Million EUR | 31.83% |
| 2020 FY | 321.47 Million EUR | 46.96% |
| 2020 Q1 | 46.2 Million EUR | 30.34% |
| 2020 Q2 | 35.3 Million EUR | -23.59% |
| 2020 Q3 | 68 Million EUR | 92.63% |
| 2020 Q4 | 77.17 Million EUR | 13.49% |
| 2019 Q4 | 35.44 Million EUR | -9.11% |
| 2019 FY | 218.74 Million EUR | 54.76% |
| 2019 Q2 | 44.5 Million EUR | 17.72% |
| 2019 Q1 | 37.8 Million EUR | -24.31% |
| 2019 Q3 | 39 Million EUR | -12.36% |
| 2018 Q3 | 34.1 Million EUR | 11.07% |
| 2018 FY | 141.34 Million EUR | 23.2% |
| 2018 Q4 | 49.94 Million EUR | 46.46% |
| 2018 Q2 | 30.7 Million EUR | 15.41% |
| 2018 Q1 | 26.6 Million EUR | -33.72% |
| 2017 FY | 114.73 Million EUR | 11.46% |
| 2017 Q4 | 40.13 Million EUR | 76.01% |
| 2017 Q3 | 22.8 Million EUR | 100.0% |
| 2017 Q2 | 11.4 Million EUR | -57.14% |
| 2017 Q1 | 26.6 Million EUR | 17.53% |
| 2016 Q4 | 22.63 Million EUR | -15.87% |
| 2016 FY | 102.93 Million EUR | -18.5% |
| 2016 Q3 | 26.9 Million EUR | -7.56% |
| 2016 Q2 | 29.1 Million EUR | 19.75% |
| 2016 Q1 | 24.3 Million EUR | 22.71% |
| 2015 Q1 | 49.8 Million EUR | 332.14% |
| 2015 Q3 | 29.6 Million EUR | 8.82% |
| 2015 Q4 | 19.8 Million EUR | -33.1% |
| 2015 FY | 126.3 Million EUR | 160.29% |
| 2015 Q2 | 27.2 Million EUR | -45.38% |
| 2014 Q2 | 11.4 Million EUR | 3.64% |
| 2014 FY | 48.52 Million EUR | -7.44% |
| 2014 Q4 | 11.52 Million EUR | -21.07% |
| 2014 Q3 | 14.6 Million EUR | 28.07% |
| 2014 Q1 | 11 Million EUR | -15.54% |
| 2013 Q4 | 13.02 Million EUR | 5.89% |
| 2013 FY | 52.42 Million EUR | 8.07% |
| 2013 Q3 | 12.3 Million EUR | -13.99% |
| 2013 Q2 | 14.3 Million EUR | 276.32% |
| 2013 Q1 | 3.8 Million EUR | -66.4% |
| 2012 FY | 48.51 Million EUR | -8.12% |
| 2012 Q4 | 11.31 Million EUR | -24.09% |
| 2012 Q1 | 15.7 Million EUR | 21.75% |
| 2012 Q2 | 13.7 Million EUR | -12.74% |
| 2012 Q3 | 14.9 Million EUR | 8.76% |
| 2011 Q3 | 16 Million EUR | 44.14% |
| 2011 Q4 | 12.89 Million EUR | -19.41% |
| 2011 Q1 | 12.8 Million EUR | -77.94% |
| 2011 Q2 | 11.1 Million EUR | -13.28% |
| 2011 FY | 52.79 Million EUR | 70.2% |
| 2010 Q3 | 10.7 Million EUR | 16.3% |
| 2010 FY | 31.02 Million EUR | 3081.54% |
| 2010 Q1 | 7.1 Million EUR | 300.0% |
| 2010 Q2 | 9.2 Million EUR | 29.58% |
| 2010 Q4 | 58.02 Million EUR | 442.24% |
| 2009 Q3 | 6.4 Million EUR | 190.14% |
| 2009 FY | 975 Thousand EUR | -94.01% |
| 2009 Q1 | 2.3 Million EUR | 0.0% |
| 2009 Q2 | -7.1 Million EUR | -408.7% |
| 2009 Q4 | 1.77 Million EUR | -72.27% |
| 2008 FY | 16.28 Million EUR | -45.96% |
| 2007 FY | 30.13 Million EUR | 3.84% |
| 2006 FY | 29.01 Million EUR | 31.75% |
| 2005 FY | 22.02 Million EUR | 44.59% |
| 2004 FY | 15.23 Million EUR | 238.74% |
| 2003 FY | 4.49 Million EUR | 1.08% |
| 2002 FY | 4.44 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 151.84 Million EUR | -35.14% |
| Carl Zeiss Meditec AG | 290.39 Million EUR | 29.338% |
| Fielmann Aktiengesellschaft | 127.64 Million EUR | -60.76% |
| Gerresheimer AG | 116.12 Million EUR | -76.705% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 0.0% |